SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-019161
Filing Date
2016-05-12
Accepted
2016-05-12 06:04:37
Documents
70
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nvet-10q_20160331.htm 10-Q 2176135
2 EX-12.1 nvet-ex121_13.htm EX-12.1 43238
3 EX-31.1 nvet-ex311_6.htm EX-31.1 10453
4 EX-31.2 nvet-ex312_7.htm EX-31.2 10144
5 EX-32.1 nvet-ex321_9.htm EX-32.1 7622
6 EX-32.2 nvet-ex322_8.htm EX-32.2 7623
  Complete submission text file 0001564590-16-019161.txt   7942860

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT nvet-20160331.xml EX-101.INS 1874234
8 XBRL TAXONOMY EXTENSION SCHEMA nvet-20160331.xsd EX-101.SCH 56414
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvet-20160331_cal.xml EX-101.CAL 41026
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvet-20160331_def.xml EX-101.DEF 164297
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvet-20160331_lab.xml EX-101.LAB 383672
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvet-20160331_pre.xml EX-101.PRE 304623
Mailing Address UNIT 5, SRAGH TECHNOLOGY PARK RAHAN ROAD TULLAMORE , CO. OFFALY L2 R35 FR98
Business Address UNIT 5, SRAGH TECHNOLOGY PARK RAHAN ROAD TULLAMORE , CO. OFFALY L2 R35 FR98 353 1 215 8100
Nexvet Biopharma plc (Filer) CIK: 0001618561 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36828 | Film No.: 161641543
SIC: 2834 Pharmaceutical Preparations